Skip to main content
Top
Published in: Gastric Cancer 1/2015

01-01-2015 | Original Article

Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients

Authors: Koji Nakada, Masami Ikeda, Masazumi Takahashi, Shinichi Kinami, Masashi Yoshida, Yoshikazu Uenosono, Yoshiyuki Kawashima, Atsushi Oshio, Yoshimi Suzukamo, Masanori Terashima, Yasuhiro Kodera

Published in: Gastric Cancer | Issue 1/2015

Login to get access

Abstract

Background

Lack of a suitable instrument to comprehensively assess symptoms, living status, and quality of life in postgastrectomy patients prompted the authors to develop postgastrectomy syndrome assessment scale (PGSAS)-45.

Methods

PGSAS-45 consists of 45 items in total: 8 items from SF-8, 15 items from GSRS, and an additional 22 items selected by 47 gastric surgeons. Using the PGSAS-45, a multi-institutional survey was conducted to determine the prevalence of postgastrectomy syndrome and its impact on everyday life among patients who underwent various types of gastrectomy. Eligible data were obtained from 2,368 patients operated and followed at 52 institutions in Japan. Of these, data from 1,777 patients were used in the current study in which symptom subscales of the PGSAS-45 were determined. We also considered the characteristics of the postgastrectomy syndrome and to what extent these symptoms influence patients’ living status and quality of life (QOL).

Results

By factor analysis, 23 symptom-related items of PGSAS-45 were successfully clustered into seven symptom subscales that represent esophageal reflux, abdominal pain, meal-related distress, indigestion, diarrhea, constipation, and dumping. These seven symptom subscales and two other subscales measuring quality of ingestion and dissatisfaction for daily life, respectively, had good internal consistency in terms of Cronbach′s α (0.65–0.88).

Conclusion

PGSAS-45 provides a valid and reliable integrated index for evaluation of symptoms, living status, and QOL in gastrectomized patients.
Literature
1.
2.
go back to reference Carvajal SH, Mulvihill SJ. Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin N Am. 1994;23(2):261–79. Carvajal SH, Mulvihill SJ. Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin N Am. 1994;23(2):261–79.
3.
go back to reference Cooperman AM. Postgastrectomy syndromes. Surg Annu. 1981;13:139–61.PubMed Cooperman AM. Postgastrectomy syndromes. Surg Annu. 1981;13:139–61.PubMed
4.
go back to reference Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin N Am. 1992;72(2):445–65.PubMed Eagon JC, Miedema BW, Kelly KA. Postgastrectomy syndromes. Surg Clin N Am. 1992;72(2):445–65.PubMed
5.
go back to reference Harju E. Metabolic problems after gastric surgery. Int Surg. 1990;75(1):27–35.PubMed Harju E. Metabolic problems after gastric surgery. Int Surg. 1990;75(1):27–35.PubMed
6.
go back to reference Jay BS, Burrell M. Iatrogenic problems following gastric surgery. Gastrointest Radiol. 1977;2(3):239–57.PubMedCrossRef Jay BS, Burrell M. Iatrogenic problems following gastric surgery. Gastrointest Radiol. 1977;2(3):239–57.PubMedCrossRef
7.
8.
go back to reference Lehnert T, Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Surg. 2004;91(5):528–39.PubMedCrossRef Lehnert T, Buhl K. Techniques of reconstruction after total gastrectomy for cancer. Br J Surg. 2004;91(5):528–39.PubMedCrossRef
9.
go back to reference Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9(2):51–66.PubMedCrossRef Maruyama K, Kaminishi M, Hayashi K, Isobe Y, Honda I, Katai H, et al. Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry. Gastric Cancer. 2006;9(2):51–66.PubMedCrossRef
10.
go back to reference Endo S, Nishida T, Nishikawa K, Yumiba T, Nakajima K, Yasumasa K, et al. Motility of the pouch correlates with quality of life after total gastrectomy. Surgery (St. Louis). 2006;139(4):493–500.CrossRef Endo S, Nishida T, Nishikawa K, Yumiba T, Nakajima K, Yasumasa K, et al. Motility of the pouch correlates with quality of life after total gastrectomy. Surgery (St. Louis). 2006;139(4):493–500.CrossRef
11.
go back to reference Hayami M, Seshimo A, Miyake K, Shimizu S, Kameoka S. Effects of emptying function of remaining stomach on QOL in postgastrectomy patients. World J Surg. 2012;36(2):373–8.PubMedCrossRef Hayami M, Seshimo A, Miyake K, Shimizu S, Kameoka S. Effects of emptying function of remaining stomach on QOL in postgastrectomy patients. World J Surg. 2012;36(2):373–8.PubMedCrossRef
12.
go back to reference Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS. Quality of life in disease-free gastric adenocarcinoma survivors: impacts of clinical stages and reconstructive surgical procedures. Dig Surg. 2007;24(1):59–65.PubMedCrossRef Huang CC, Lien HH, Wang PC, Yang JC, Cheng CY, Huang CS. Quality of life in disease-free gastric adenocarcinoma survivors: impacts of clinical stages and reconstructive surgical procedures. Dig Surg. 2007;24(1):59–65.PubMedCrossRef
13.
go back to reference Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg. 2011;35(2):357–64.PubMedCrossRef Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A. Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg. 2011;35(2):357–64.PubMedCrossRef
14.
go back to reference Kono K, Iizuka H, Sekikawa T, Sugai H, Takahashi A, Fujii H, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg. 2003;185(2):150–4.PubMedCrossRef Kono K, Iizuka H, Sekikawa T, Sugai H, Takahashi A, Fujii H, et al. Improved quality of life with jejunal pouch reconstruction after total gastrectomy. Am J Surg. 2003;185(2):150–4.PubMedCrossRef
15.
go back to reference Lee MS, Ahn SH, Lee JH, Park do J, Lee HJ, Kim HH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc. 2012;26(6):1539–47. Lee MS, Ahn SH, Lee JH, Park do J, Lee HJ, Kim HH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc. 2012;26(6):1539–47.
16.
go back to reference Nakamura M, Kido Y, Yano M, Hosoya Y. Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma. Surg Today. 2005;35(7):535–42.PubMedCrossRef Nakamura M, Kido Y, Yano M, Hosoya Y. Reliability and validity of a new scale to assess postoperative dysfunction after resection of upper gastrointestinal carcinoma. Surg Today. 2005;35(7):535–42.PubMedCrossRef
17.
go back to reference Nakane Y, Michiura T, Inoue K, Iiyama H, Okumura S, Yamamichi K, et al. A randomized clinical trial of pouch reconstruction after total gastrectomy for cancer: which is the better technique, Roux-en-Y or interposition? Hepatogastroenterology. 2001;48(39):903–7.PubMed Nakane Y, Michiura T, Inoue K, Iiyama H, Okumura S, Yamamichi K, et al. A randomized clinical trial of pouch reconstruction after total gastrectomy for cancer: which is the better technique, Roux-en-Y or interposition? Hepatogastroenterology. 2001;48(39):903–7.PubMed
18.
go back to reference Namikawa T, Kitagawa H, Okabayashi T, Sugimoto T, Kobayashi M, Hanazaki K. Roux-en-Y reconstruction is superior to Billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of His. World J Surg. 2010;34(5):1022–7.PubMedCrossRef Namikawa T, Kitagawa H, Okabayashi T, Sugimoto T, Kobayashi M, Hanazaki K. Roux-en-Y reconstruction is superior to Billroth I reconstruction in reducing reflux esophagitis after distal gastrectomy: special relationship with the angle of His. World J Surg. 2010;34(5):1022–7.PubMedCrossRef
19.
go back to reference Nunobe S, Okaro A, Sasako M, Saka M, Fukagawa T, Katai H, et al. Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol. 2007;12(6):433–9.PubMedCrossRef Nunobe S, Okaro A, Sasako M, Saka M, Fukagawa T, Katai H, et al. Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol. 2007;12(6):433–9.PubMedCrossRef
20.
go back to reference Svedlund J, Sullivan M, Liedman B, Lundell L, Sjodin I. Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg. 1997;21(4):422–33.PubMedCrossRef Svedlund J, Sullivan M, Liedman B, Lundell L, Sjodin I. Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg. 1997;21(4):422–33.PubMedCrossRef
21.
go back to reference Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15(2):198–205.PubMedCrossRef Takiguchi S, Yamamoto K, Hirao M, Imamura H, Fujita J, Yano M, et al. A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer. 2012;15(2):198–205.PubMedCrossRef
22.
go back to reference Karanicolas PJ, Bickenbach K, Jayaraman S, Pusic AL, Coit DG, Guyatt GH, et al. Measurement and interpretation of patient-reported outcomes in surgery: an opportunity for improvement. J Gastrointest Surg. 2011;15(4):682–9.PubMedCrossRef Karanicolas PJ, Bickenbach K, Jayaraman S, Pusic AL, Coit DG, Guyatt GH, et al. Measurement and interpretation of patient-reported outcomes in surgery: an opportunity for improvement. J Gastrointest Surg. 2011;15(4):682–9.PubMedCrossRef
24.
go back to reference Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis. 1998;16(5):315–24.PubMedCrossRef Moyer CA, Fendrick AM. Measuring health-related quality of life in patients with upper gastrointestinal disease. Dig Dis. 1998;16(5):315–24.PubMedCrossRef
25.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.PubMedCrossRef
26.
go back to reference Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966–71.PubMedCrossRef Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966–71.PubMedCrossRef
27.
go back to reference Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003;12(8):1003–12.PubMedCrossRef Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003;12(8):1003–12.PubMedCrossRef
28.
go back to reference Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–34.PubMedCrossRef Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–34.PubMedCrossRef
29.
go back to reference Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7(1):75–83.PubMedCrossRef Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7(1):75–83.PubMedCrossRef
30.
go back to reference Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Development and validation of PGSAS-45, an integrated questionnaire to assess postgastrectomy syndrome. Gastroenterology. 2013;144(5 suppl 1):S-1111. Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, et al. Development and validation of PGSAS-45, an integrated questionnaire to assess postgastrectomy syndrome. Gastroenterology. 2013;144(5 suppl 1):S-1111.
Metadata
Title
Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients
Authors
Koji Nakada
Masami Ikeda
Masazumi Takahashi
Shinichi Kinami
Masashi Yoshida
Yoshikazu Uenosono
Yoshiyuki Kawashima
Atsushi Oshio
Yoshimi Suzukamo
Masanori Terashima
Yasuhiro Kodera
Publication date
01-01-2015
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2015
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-014-0344-4

Other articles of this Issue 1/2015

Gastric Cancer 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.